Laboratory
Molecular Imaging and Nanotherapeutics
Haikun Liu is a Research Officer in the Molecular Imaging and Nanotherapeutics lab. His research focuses on developing novel mRNA delivery systems for cardiovascular disease.
mRNA therapies have attracted significant attention since their successful use during the COVID-19 pandemic. However, their application to cardiovascular disease remains limited by the lack of safe, efficient delivery systems that can target specific tissues and sustain therapeutic protein expression. Haikun’s research addresses this challenge using nanoparticle-based delivery approaches.
Achievements
- AINSE Conference Scholarship (2024
- Harold Mitchell Travel Fellowship (2024)
- University of Melbourne - Baker Institute Seed Funding
- AINSE Ltd Postgraduate Research Award
- Cardiometabolic Health Scholarship, University of Melbourne, Australia (2022)
- Clarence C. Gibson Scholarship, Carleton University, Ontario, Canada (2018)
- E.W.R. Steacie Scholarship, Carleton University, Ontario, Canada (2017)
Awards
- ISHR2025 Travel Award, ISHR World Congress (2025)
- Harold Mitchell Travel Fellowship, Baker Heart and Diabetes Institute (2024)
- The AINSE Conference Scholarship, AINSE (2024)
- Best Student Oral Presentation, Australian Society of Molecular Imaging Annual Scientific Meeting (2023)
- Bright Sparks Travel Award, Baker Heart and Diabetes Institute (2023)
- Postgraduate Research Award, AINSE (2023)
